ITULAZAX<sup>®</sup> versus Alutard SQ<sup>®</sup> in the treatment of allergic rhinitis induced by pollen from the birch homologous group: A cost-minimization modeling analysis from the Danish societal perspective.
Journal Information
Full Title: Clin Transl Allergy
Abbreviation: Clin Transl Allergy
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"CONFLICTS OF INTEREST Steen M. Ronborg has received advisor and consultancy fees from ALK‐Abelló A/S; Henrik Brandi and Tobias Sydendal Grand were full‐time employees of ALK‐Abelló A/S at the time of the study; and Richard F. Pollock is the director and shareholder of Covalence Research Ltd, which received consultancy fees from ALK‐Abelló A/S to conduct the analyses and draft the manuscript."
Funding Disclosure
Evidence found in paper:
"This manuscript was supported by an unrestricted grant from ALK‐Abelló A/S."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025